CIK 0000949858 · Non-accelerated filer<br>Smaller reporting company
ACHIEVE LIFE SCIENCES, INC.
Sign in to watch- Ticker
- ACHV
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 954343413
- Phone
- 425-686-1500
- Business address
- 22722 29TH DR. SE, SUITE 100, SEATTLE, WA, 98021
- Former names
- ONCOGENEX PHARMACEUTICALS, INC., SONUS PHARMACEUTICALS INC
- EFFECT Other Notice of Effectiveness
- CORRESP Other Correspondence Between Filers and SEC Staff
- S-1/A Offering Registration Statement
- UPLOAD Other SEC-generated Letter
- S-1 Offering Registration Statement
- SC 13G/A Stake Amended Statement of Ownership
- 4 Open-market sale 10% owner sold 47,182 shares at an average $2.86 ($134,821)
- 4 Open-market sale 10% owner sold 264,963 shares at an average $3.16 ($837,467)
- 8-K Event Other events
- 3 Insider Initial Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- 8-K Event Material agreement
- 424B5 Offering Prospectus
- 8-K Event Material agreement · Unregistered share sale
- SC 13G Stake Amended Statement of Ownership
- 4 Open-market buy Chairman & CEO bought 17,500 shares at $3.61 ($63,093)
- 424B5 Offering Prospectus
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- S-8 Other Securities Offered to Employees in Benefit Plans
Page 23 of 68 · 1,358 filings